GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 76 filers reported holding GAMIDA CELL LTD in Q1 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,996,404 | -18.4% | 1,547,600 | +0.6% | 0.01% | -14.3% |
| Q3 2022 | $2,446,000 | -26.1% | 1,538,348 | -17.7% | 0.01% | -22.2% |
| Q2 2022 | $3,308,000 | -84.5% | 1,868,896 | -63.6% | 0.01% | -81.2% |
| Q1 2022 | $21,282,000 | +92.0% | 5,128,300 | +17.5% | 0.05% | +128.6% |
| Q4 2021 | $11,083,000 | -39.7% | 4,363,315 | -6.9% | 0.02% | -40.0% |
| Q3 2021 | $18,371,000 | -38.8% | 4,686,565 | 0.0% | 0.04% | -37.5% |
| Q2 2021 | $30,041,000 | -20.8% | 4,686,565 | 0.0% | 0.06% | -24.3% |
| Q1 2021 | $37,914,000 | -10.6% | 4,686,565 | -7.2% | 0.07% | -14.9% |
| Q4 2020 | $42,391,000 | +474.6% | 5,052,523 | +184.2% | 0.09% | +411.8% |
| Q3 2020 | $7,378,000 | -9.2% | 1,777,777 | 0.0% | 0.02% | -15.0% |
| Q2 2020 | $8,124,000 | – | 1,777,777 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
| Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
| Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
| Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
| Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
| FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
| Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
| PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |